Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled PC945 for Aspergillus Colonisation in Lung Transplant
NCT03905447Phase 2Terminated
- Sponsor
- Pulmocide
- Start
- Sep 2019
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of opelconazole in aspergillosis, sponsored by Pulmocide. Started Sep 2019; status: terminated.
02
Drugs
opelconazole
03
Conditions
aspergillosis
Beyond the preview
Go deeper on NCT03905447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03905447.